Rights and permissions
About this article
Cite this article
Irinotecan + nedaplatin promising for advanced or recurrent cervical cancer. Inpharma Wkly. 1462, 14 (2004). https://doi.org/10.2165/00128413-200414620-00032
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414620-00032